Glumac et al. conjugated PET probe 89Zr-HA10 IgG for CD133+ tumor imaging and validated its specificity using CD133+ and CD133− aggressive variant prostate cancer tumor-bearing mice. The gene discussed is PROM1; the disease is prostate carcinoma.